Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with...
Saved in:
Main Authors: | Miguel Cordero-Coma (Author), Vanesa Calvo-Río (Author), Alfredo Adán (Author), Ricardo Blanco (Author), Carolina Álvarez-Castro (Author), Marina Mesquida (Author), Sara Calleja (Author), Miguel A. González-Gay (Author), José G. Ruíz de Morales (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021) -
Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
by: Carmen García-, et al.
Published: (2013) -
Infliximab as rescue therapy in refractory Kawasaki disease
by: Moisés Rodríguez-González, et al.
Published: (2014) -
Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet's Disease
by: Marina Mesquida, et al.
Published: (2014) -
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020)